One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA.
about
Cardiac cachexia: hic et nuncBody mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1.Cachexia & debility diagnoses in hospitalized children and adolescents with complex chronic conditions: evidence from the Kids' Inpatient Database.STAT3 in the systemic inflammation of cancer cachexia.THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES.Cachexia among US cancer patients.Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact.Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study.Sex Differences in Muscle Wasting.Experimental Evidences Supporting the Benefits of Exercise Training in Heart Failure.Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer.
P2860
Q26744140-4D45A782-C465-4153-9211-599CBE95C58EQ33813557-D32CA40B-2B30-409A-910A-CB86FFE0B1B9Q35157920-7F152948-361B-40F4-9A55-AC4068D43954Q36901910-8F625997-D5F4-4C8B-90BF-50143474C5BBQ39032975-32D63DA4-262A-4887-B024-F05F46764A22Q39834455-717BB708-E391-4EEF-9723-5A2BFDD5F241Q41787049-E38AC578-1D4E-4969-8933-EC7860616C92Q42366313-F32CB05F-A87F-493D-8A76-F712DE0BE5A5Q42793406-6A815347-0BF8-46F2-ABA0-7C38792831CEQ47137154-FCDE4DDF-19A9-4350-9B15-068459C4615DQ47311543-10397A51-2496-4072-AF80-E91DABBD1154Q48023234-CE46E1DE-B640-4F07-8D38-6DC83BA09D0EQ54935754-AD3DA838-78ED-4CE3-AEFA-2F0A1870CCF8
P2860
One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
One-year prevalence, comorbidi ...... patient admissions in the USA.
@ast
One-year prevalence, comorbidi ...... patient admissions in the USA.
@en
One-year prevalence, comorbidi ...... patient admissions in the USA.
@nl
type
label
One-year prevalence, comorbidi ...... patient admissions in the USA.
@ast
One-year prevalence, comorbidi ...... patient admissions in the USA.
@en
One-year prevalence, comorbidi ...... patient admissions in the USA.
@nl
prefLabel
One-year prevalence, comorbidi ...... patient admissions in the USA.
@ast
One-year prevalence, comorbidi ...... patient admissions in the USA.
@en
One-year prevalence, comorbidi ...... patient admissions in the USA.
@nl
P2093
P2860
P356
P1433
P1476
One-year prevalence, comorbidi ...... npatient admissions in the USA
@en
P2093
Christopher M Blanchette
Debosoree Roy
Joshua M Noone
Susan Tsivitse Arthur
P2860
P304
P356
10.7573/DIC.212265
P577
2014-07-31T00:00:00Z